Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2017 2
2021 1
2022 2
2023 1
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year

Filters applied: . Clear all
Page 1
Trial of Anti-BDCA2 Antibody Litifilimab for Cutaneous Lupus Erythematosus.
Werth VP, Furie RA, Romero-Diaz J, Navarra S, Kalunian K, van Vollenhoven RF, Nyberg F, Kaffenberger BH, Sheikh SZ, Radunovic G, Huang X, Clark G, Carroll H, Naik H, Gaudreault F, Meyers A, Barbey C, Musselli C, Franchimont N; LILAC Trial Investigators. Werth VP, et al. N Engl J Med. 2022 Jul 28;387(4):321-331. doi: 10.1056/NEJMoa2118024. N Engl J Med. 2022. PMID: 35939578 Clinical Trial.
Trial of Anti-BDCA2 Antibody Litifilimab for Systemic Lupus Erythematosus.
Furie RA, van Vollenhoven RF, Kalunian K, Navarra S, Romero-Diaz J, Werth VP, Huang X, Clark G, Carroll H, Meyers A, Musselli C, Barbey C, Franchimont N; LILAC Trial Investigators. Furie RA, et al. N Engl J Med. 2022 Sep 8;387(10):894-904. doi: 10.1056/NEJMoa2118025. N Engl J Med. 2022. PMID: 36069871 Clinical Trial.
Autoimmune/inflammatory syndrome induced by adjuvants in a woman with Hashimoto thyroiditis and familial autoimmunity-a case report and literature review.
Plavsic A, Arandjelovic S, Dimitrijevic M, Kusic N, Tomic Spiric V, Popovic B, Jovicic Z, Peric Popadic A, Miskovic R. Plavsic A, et al. Among authors: arandjelovic s. Front Immunol. 2023 May 23;14:1139603. doi: 10.3389/fimmu.2023.1139603. eCollection 2023. Front Immunol. 2023. PMID: 37287963 Free PMC article. Review.
Asthma Inflammatory Phenotypes: How Can We Distinguish Them?
Plavsic A, Bonaci-Nikolic B, Milenkovic B, Miskovic R, Kusic N, Dimitrijevic M, Arandjelovic S, Milosevic K, Buha I, Tomic Spiric V. Plavsic A, et al. Among authors: arandjelovic s. J Clin Med. 2024 Jan 17;13(2):526. doi: 10.3390/jcm13020526. J Clin Med. 2024. PMID: 38256660 Free PMC article.
Biomarkers of disease activity in patients with chronic spontaneous urticaria.
Plavsic A, Tomic-Spiric V, Arandjelovic S, Miskovic R, Dimitrijevic M, Peric-Popadic A. Plavsic A, et al. Among authors: arandjelovic s. Postepy Dermatol Alergol. 2021 Dec;38(6):1017-1022. doi: 10.5114/ada.2021.112276. Epub 2022 Jan 7. Postepy Dermatol Alergol. 2021. PMID: 35126009 Free PMC article.
[Laboratory and morphologic parameters in patients with lupus nephritis].
Rasković S, Bogić M, Perić-Popadić A, Stefanović L, Arandjelović S, Jovicić Z, Bolpacić J, Tomić-Spirić V. Rasković S, et al. Among authors: arandjelovic s. Srp Arh Celok Lek. 2002 Aug;130 Suppl 3:38-41. Srp Arh Celok Lek. 2002. PMID: 12583312 Serbian.